Peter Turecek
118Patents
16h-index
83Co-inventors
89Inventor score
Filing activity: Mar 30, 1993 → Dec 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5883078A | Hemostyptic and tissue adhesive | Human Necessities | 88 | Expired |
| US6224862A | Pharmaceutical preparation for treating blood coagulation disorders | Chemistry; Metallurgy | 74 | Expired |
| US6017891A | Stable preparation for the treatment of blood coagulation disorders | Chemistry; Metallurgy | 62 | Expired |
| US6013620A | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use | Chemistry; Metallurgy | 41 | Expired |
| US5891843A | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use | Chemistry; Metallurgy | 40 | Expired |
| US5854403A | Method for isolation of highly pure von Willebrand Factor | Human Necessities | 28 | Expired |
| US5698677A | Stable preparation for the treatment of blood coagulation disorders | Chemistry; Metallurgy | 26 | Expired |
| US5866122A | Pharmaceutical preparation for treating blood coagulation disorders | Chemistry; Metallurgy | 24 | Expired |
| US6919311B2 | Factor VII polypeptide having factor VII:C activity | Human Necessities | 23 | Expired |
| US7993580B2 | Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors | Electricity | 23 | Active |
| US7645860B2 | Factor VIII polymer conjugates | Human Necessities | 22 | Active |
| US6270672A | Devices and methods for removing pathogens from biological fluids | Performing Operations; Transporting | 20 | Expired |
| US6005077A | Use of von willebrand factor and pharmaceutical formulation | Physics | 19 | Expired |
| US6926894B2 | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV | Chemistry; Metallurgy | 19 | Expired |
| US6103693A | Method for isolation of highly pure von willebrand factor | Human Necessities | 17 | Expired |
| US5410022A | Method of producing a factor VIII preparation | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6358534B1 | Immunotolerant prothrombin complex preparation | Human Necessities | 15 | Expired |
| US5880265A | Method for isolation of highly pure von willebrand factor | Human Necessities | 15 | Expired |
| US8945897B2 | Materials and methods for conjugating a water soluble fatty acid derivative to a protein | Human Necessities | 14 | Active |
| US6777390B1 | Stable blood coagulation inhibitor-free factor vii preparation and method for preparing same | Human Necessities | 14 | Expired |
| US8546096B2 | Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI | Physics | 14 | Active |
| US7884075B2 | Polymer-factor VIII-von Willebrand factor-conjugates | Chemistry; Metallurgy | 13 | Active |
| US7683158B2 | Pegylated factor VIII | Chemistry; Metallurgy | 12 | Active |
| US8986607B2 | Method for the validatable inactivation of pathogens in a biological fluid by irradiation | Chemistry; Metallurgy | 12 | Active |
| US5639730A | Method of producing a virus-safe biological preparation | Emerging Cross-Sectional Technologies | 12 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.